Parameter
| Biomarker | ctDNA | Full name | Circulating tumors DNA | Molecular Type | Nucleic acids (DNA) |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Non-invasive diagnosis, clonal evolution monitoring, and drug resistance mechanism exploration |
| Disease | Pleural Mesothelioma | Disease Subtypes | / | ||
| Organ | pleura | Test Sample / Technology Platform | pleura Blood (specific technology platform not specified) | ||
| Pathobiological Mechanisms | Carrying PM-related gene mutations or methylation abnormalities reflecting tumor genomic characteristics | ||||
| Clinical Availability Status | Cutting-edge research stage: It provides the possibility for non-invasive diagnosis of PM, but has not yet entered clinical application | ||||
| Notes and Dynamics | It can be used for non-invasive diagnosis of PM, dynamic monitoring of tumor clonal evolution, and exploration of drug resistance mechanisms | ||||